Journal article
Authors list: Bretzel, RG; Brendel, M; Eckhard, M; Brandhorst, D; Jaeger, C; Hatziagelaki, E; Federlin, K
Publication year: 2001
Pages: S384-S399
Journal: Experimental and Clinical Endocrinology & Diabetes
Volume number: 109
ISSN: 0947-7349
eISSN: 1439-3646
DOI Link: https://doi.org/10.1055/s-2001-18597
Publisher: Thieme Publishing
Abstract:
Beta-cell replacement either by pancreatic organ or islet cell transplantation is the only treatment to achieve an insulin-independent, normoglycemic state and to avoid hypoglycemic episodes in patients with type 1 diabetes mellitus, This article will review the state-of-the-art in clinical islet cell personal experience. transplantation at the dawn of the new millenium and will provide an outlook on the basis of extended personal experience.
Citation Styles
Harvard Citation style: Bretzel, R., Brendel, M., Eckhard, M., Brandhorst, D., Jaeger, C., Hatziagelaki, E., et al. (2001) Islet transplantation: Present clinical situation and future aspects, Experimental and Clinical Endocrinology & Diabetes, 109, pp. S384-S399. https://doi.org/10.1055/s-2001-18597
APA Citation style: Bretzel, R., Brendel, M., Eckhard, M., Brandhorst, D., Jaeger, C., Hatziagelaki, E., & Federlin, K. (2001). Islet transplantation: Present clinical situation and future aspects. Experimental and Clinical Endocrinology & Diabetes. 109, S384-S399. https://doi.org/10.1055/s-2001-18597
Keywords
ACID DECARBOXYLASE ANTIBODIES; ALLOGRAFT SURVIVAL; alloimmunity; AUTOIMMUNITY; CELL ANTIBODIES; DIABETES-MELLITUS; DONOR; Gene therapy; immunotolerance; INSULIN INDEPENDENCE; ISLET TRANSPLANTATION; Kidney transplantation; LONG-TERM SURVIVAL; PANCREATIC-ISLET
